Facet joint septic arthritis due to community acquired methicillin resistant Staphylococcus aureus (MRSA) - A case

Rajesh Purushothaman1, Jojo Inassi1, Anwar Marthya2

  • 1Department of Orthopaedics, Medical College, Calicut, 673009, India.

Journal of Orthopaedics
|January 1, 2016
PubMed

Insights

Septic arthritis of the facet joint (SAFJ) is rare, often caused by Staphylococcus aureus. This case highlights successful treatment of community-acquired methicillin-resistant S aureus (MRSA) SAFJ using Linezolid.

Area of Science:

  • Spinal infections
  • Rheumatology
  • Infectious diseases

Background:

  • Septic arthritis of the facet joint (SAFJ) is an exceptionally rare condition, with limited documented cases.
  • Historically, only about sixty cases have been reported, with initial reports dating back to 1981.
  • Increased utilization of MRI has led to more frequent diagnoses of SAFJ.

Purpose of the Study:

  • To report a rare case of septic arthritis of the facet joint (SAFJ).
  • To highlight the causative organism, community-acquired methicillin-resistant Staphylococcus aureus (MRSA).
  • To present a successful treatment strategy using Linezolid.

Main Methods:

  • Case report detailing a patient diagnosed with SAFJ.
  • Identification of Staphylococcus aureus as the causative pathogen.
  • Treatment administered with the antibiotic Linezolid.

Main Results:

  • The patient presented with SAFJ caused by community-acquired MRSA.
  • Successful treatment outcome was achieved with Linezolid therapy.
  • This case adds to the limited literature on SAFJ, particularly those caused by MRSA.

Conclusions:

  • Septic arthritis of the facet joint (SAFJ) is a rare but significant spinal infection.
  • Community-acquired MRSA can be an etiological agent for SAFJ.
  • Linezolid demonstrates efficacy in treating MRSA-induced SAFJ.

Related Concept Videos